Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Angela MY. Chan"'
Autor:
Angela MY. Chan, Gloria Roldan Urgoiti, Will Jiang, Sandra Lee, Elizabeth Kornaga, Peter Mathen, Rosanna Yeung, Emeka K. Enwere, Alan Box, Mie Konno, Martin Koebel, Kurian Joseph, Corinne M. Doll
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundProgrammed death-ligand 1 (PD-L1) expression has been shown to be prognostic in many cancer types and used in consideration of checkpoint inhibitor immunotherapy. However, there are very limited and conflicting data on the prognostic impact
Externí odkaz:
https://doaj.org/article/c4113dee65734a5691f506b596a4b519
Autor:
Angela MY Chan, Emeka Enwere, John B McIntyre, Holly Wilson, Chidera Nwaroh, Nicholas Wiebe, Young Ou, Shuhong Liu, Katharina Wiedemeyer, Peter F Rambau, Xin Grevers, Donald G Morris, Paola Neri, C Blake Gilks, Frank Visser, Nhu Le, Li Luo, Linda S Cook, Martin Köbel
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 6, Iss 4, Pp 252-262 (2020)
Abstract CCNE1 amplification is a recurrent alteration associated with unfavourable outcome in tubo‐ovarian high‐grade serous carcinoma (HGSC). We aimed to investigate whether immunohistochemistry (IHC) can be used to identify CCNE1 amplification
Externí odkaz:
https://doaj.org/article/6ee18146a012411aa9e07aebf83b2262
Autor:
Angela MY Chan, Tasnima Abedin, Satbir Thakur, HaoCheng Li, Mie Konno, Emeka Enwere, Sasha Lupichuk, Nancy Nixon, Donald Morris, Hua Yang, Paola Neri
Publikováno v:
Cancer Research. 82:P1-08
Background: Breast cancer prognosis and systemic treatment is mainly determined by its molecular subtype defined by the expression of driver genes including ER, PR, HER2 and Ki67. Several assays which include these key genes are currently available f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06809f5a959508ac2393e939381a2f91
https://doi.org/10.1158/1538-7445.sabcs21-p1-08-01
https://doi.org/10.1158/1538-7445.sabcs21-p1-08-01
Autor:
Shuhong Liu, Holly E Wilson, John B. McIntyre, Paola Neri, Young Ou, Chidera Nwaroh, C. Blake Gilks, Donald Morris, Martin Köbel, Li Luo, Frank Visser, Emeka K. Enwere, Peter F Rambau, Katharina Wiedemeyer, Xin Grevers, Linda S. Cook, Nicholas Wiebe, Nhu D. Le, Angela My Chan
Publikováno v:
The Journal of Pathology: Clinical Research
The Journal of Pathology: Clinical Research, Vol 6, Iss 4, Pp 252-262 (2020)
The Journal of Pathology: Clinical Research, Vol 6, Iss 4, Pp 252-262 (2020)
CCNE1 amplification is a recurrent alteration associated with unfavourable outcome in tubo‐ovarian high‐grade serous carcinoma (HGSC). We aimed to investigate whether immunohistochemistry (IHC) can be used to identify CCNE1 amplification status a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c4efec27a75665d7ec3dc5a8a8b691e
https://doi.org/10.1002/cjp2.168
https://doi.org/10.1002/cjp2.168